Company Filing History:
Years Active: 2022-2024
Title: Uwe Hahn: Innovator in Amino Diaryl Ethers
Introduction
Uwe Hahn is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of amino diaryl ethers. With a total of two patents to his name, his work has implications for various applications in pharmaceuticals and chemical manufacturing.
Latest Patents
Uwe Hahn's latest patents focus on a process for making amino diaryl ethers and their hydrochloride salts. The invention describes a method for producing a compound of formula (I) by reducing a compound of formula (II) with hydrogen in the presence of a palladium catalyst and a suitable solvent. The solvent used in this process is either a polar, aprotic solvent or a C3-C10 alcohol. Additionally, the invention includes the hydrochloride salt and monohydrochloride salt of the compound of formula (I), along with the process for their production.
Career Highlights
Uwe Hahn is currently employed at Cellestia Biotech AG, where he continues to innovate and develop new chemical processes. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Uwe has collaborated with notable colleagues, including Michael Bauer and Erhard Bappert. These partnerships have fostered a collaborative environment that enhances the research and development efforts at Cellestia Biotech AG.
Conclusion
Uwe Hahn's contributions to the field of chemistry, particularly through his patents on amino diaryl ethers, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the industry and pave the way for future developments.